Global Pharmaceuticals & Biotech Nano Cap Stocks

Planet 13 Holdings

Market Cap: CA$68.7m

Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States.

aTyr Pharma

Market Cap: US$49.3m

A clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States.

Synbio Tech

Market Cap: NT$1.6b

Manufactures and sells human healthcare products and probiotics for animals.

Cantargia

Market Cap: SEK 459.9m

A biotechnology company, develops pharmaceuticals for treatment of cancer, inflammatory, and autoimmune diseases.

Sinsin Pharmaceutical

Market Cap: ₩67.4b

Manufactures and sells pharmaceutical products in South Korea.

Decibel Cannabis

Market Cap: CA$66.4m

An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.

Austar Lifesciences

Market Cap: HK$376.7m

An investment holding company, provides integrated engineering solutions to pharmaceutical manufacturers and research institutes in Mainland China and internationally.

May & Baker Nigeria

Market Cap: ₦63.8b

May & Baker Nigeria Plc, together with its subsidiaries, manufactures, sells, and distributes human pharmaceuticals, human vaccines, and consumer products in Nigeria.

InterCure

Market Cap: ₪141.0m

Engages in the production, manufacturing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally.

Norda

Market Cap: NOK 443.4m

A biotechnology company, engages in the cancer diagnostic activities.

Grace Therapeutics

Market Cap: US$46.3m

Engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada.

biote

Market Cap: US$46.1m

Operates in practice-building business within the hormone optimization space.

Covalon Technologies

Market Cap: CA$62.1m

Engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, the Middle East, Canada, Latin America, Asia, and internationally.

Uni-Bio Science Group

Market Cap: HK$352.3m

An investment holding company, researches and develops, manufactures, and sells biological and chemical pharmaceutical products to treat human diseases in Hong Kong, and People’s Republic of China.

Little Green Pharma

Market Cap: AU$59.6m

Produces and sells cannabis-based medicinal products across Australia and Europe.

Yuyu Pharma

Market Cap: ₩59.1b

Develops and markets pharmaceutical products in Korea and United States.

Wai Yuen Tong Medicine Holdings

Market Cap: HK$323.2m

An investment holding company, engages in production and sale of Chinese and western pharmaceuticals and health food products in Mainland China and Hong Kong.

P&K Skin Research Center

Market Cap: ₩55.7b

Engages in the evaluation and research of dermatological products in South Korea.

Navamedic

Market Cap: NOK 370.5m

A pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally.

WDB coco

Market Cap: JP¥6.2b

Provides outsourcing and support services for pharmaceutical and medical device development in Japan.

Botanix Pharmaceuticals

Market Cap: AU$54.7m

Operates as a commercial dermatology company in Australia and the United States.

Medical Developments International

Market Cap: AU$53.5m

Manufactures and distributes emergency medical solutions in Australia, Asia, Europe, the United States, and internationally.

Rhone Ma Holdings Berhad

Market Cap: RM 150.9m

An investment holding company, engages in the manufacture, trading, marketing, and distribution of biotechnology and animal health products primarily in Malaysia.

MindMaze Therapeutics Holding

Market Cap: CHF 29.0m

Operates as a commercial-stage biopharmaceutical and neurotechnology company in Asia, the United States, Switzerland, rest of Europe, and internationally.

RP Bio

Market Cap: ₩50.3b

A bio-health company, engages in the research, development, manufacture, and sale of soft capsules in Korea and internationally.

Infinium Pharmachem

Market Cap: ₹3.4b

Engages in the manufacture and supply of iodine, iodine derivatives, and active pharmaceutical ingredients (APIs) in India and internationally.

Beit Jala Pharmaceutical

Market Cap: د.أ25.3m

Engages in the manufacture and sale of pharmaceutical products in the Palestinian Authority.

Prince Pharmaceutical

Market Cap: NT$1.1b

Manufactures and sells vitamin B1 active pharmaceutical ingredients (APIs) in Taiwan, Japan, Korea, and internationally.

SkinBioTherapeutics

Market Cap: UK£24.6m

A life science company, engages in research and development, and commercialization of technology that harnesses the microbiome for human health in the United Kingdom, the United States, Europe, and internationally.

Sprint Bioscience

Market Cap: SEK 317.6m

A pharmaceutical company, engages in the development of drug candidates to treat cancer in Sweden.

Genetics Generation Advancement

Market Cap: NT$1.1b

Engages in the development and implementation of digital data management systems for gene testing, biological, chemical, and materials information in Taiwan.

Winston Medical Supply

Market Cap: NT$992.7m

Develops, manufactures, and distributes pharmaceuticals, nutrition supplements, and cosmeceutical products in Taiwan and internationally.

Radiopharm Theranostics

Market Cap: AU$43.4m

A clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs.

Earth Science Tech

Market Cap: US$30.8m

Together with its subsidies, focuses on health and wellness industry.

Seach Medical Group

Market Cap: ₪89.1m

Manufactures and sells medicinal cannabis products worldwide.

Seoulin BioscienceLtd

Market Cap: ₩40.6b

A bio healthcare company, provides solutions in life sciences and healthcare primarily in South Korea.